BPC 157: Experimental Peptide Creates Risk for Athletes BPC 157 Ligament: 1 Unsafe Truth FDA to Evaluate 7 Peptides for Compounding Pharmacy Approval The Dermatology Digest posted on the topic LinkedIn The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York